Cargando…

Descriptive analysis of adverse drug reaction reports for hypersensitivity reactions stratified in relation to different beta-lactam antibiotics

β-lactam antibiotics (BLA) are commonly reported to induce hypersensitivity reactions. However, β-lactam antibiotic-stratified analyses are rare. In the presented study, β-lactam antibiotic associated hypersensitivity reactions were analyzed in the European adverse drug reaction (ADR) database. 923,...

Descripción completa

Detalles Bibliográficos
Autores principales: Dubrall, Diana, Schulz, Maike, Schmid, Matthias, Sachs, Bernhardt
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dustri-Verlag Dr. Karl Feistle 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8822522/
https://www.ncbi.nlm.nih.gov/pubmed/35141466
http://dx.doi.org/10.5414/ALX02189E
_version_ 1784646621466722304
author Dubrall, Diana
Schulz, Maike
Schmid, Matthias
Sachs, Bernhardt
author_facet Dubrall, Diana
Schulz, Maike
Schmid, Matthias
Sachs, Bernhardt
author_sort Dubrall, Diana
collection PubMed
description β-lactam antibiotics (BLA) are commonly reported to induce hypersensitivity reactions. However, β-lactam antibiotic-stratified analyses are rare. In the presented study, β-lactam antibiotic associated hypersensitivity reactions were analyzed in the European adverse drug reaction (ADR) database. 923, 38, 222, and 99 hypersensitivity reports for penicillins and first-, second- and third-generation cephalosporins were reported. Differences with regard to demographical parameters, seriousness and types of hypersensitivity reactions, as well as in the number of hypersensitivity reports per outpatient prescriptions were observed between the different β-lactam antibiotics. The number of ADR reports classified as serious was higher for all generations of cephalosporins compared to penicillins. Additionally, anaphylactic reactions were more often reported for first- and second-generation cephalosporins compared to third-generation cephalosporins and penicillins, while bullous reactions were more often reported for first- and third-generation cephalosporins as opposed to second-generation cephalosporins and penicillins. The observed differences may be caused by differences between β-lactam antibiotics and their routes of administration (oral, intravenous), the patient populations, or the reporting of ADRs. Due to the methodological limitations of ADR database analysis, no conclusions can be drawn whether and to what extent the aforementioned factors influenced our results.
format Online
Article
Text
id pubmed-8822522
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Dustri-Verlag Dr. Karl Feistle
record_format MEDLINE/PubMed
spelling pubmed-88225222022-02-08 Descriptive analysis of adverse drug reaction reports for hypersensitivity reactions stratified in relation to different beta-lactam antibiotics Dubrall, Diana Schulz, Maike Schmid, Matthias Sachs, Bernhardt Allergol Select Research Article β-lactam antibiotics (BLA) are commonly reported to induce hypersensitivity reactions. However, β-lactam antibiotic-stratified analyses are rare. In the presented study, β-lactam antibiotic associated hypersensitivity reactions were analyzed in the European adverse drug reaction (ADR) database. 923, 38, 222, and 99 hypersensitivity reports for penicillins and first-, second- and third-generation cephalosporins were reported. Differences with regard to demographical parameters, seriousness and types of hypersensitivity reactions, as well as in the number of hypersensitivity reports per outpatient prescriptions were observed between the different β-lactam antibiotics. The number of ADR reports classified as serious was higher for all generations of cephalosporins compared to penicillins. Additionally, anaphylactic reactions were more often reported for first- and second-generation cephalosporins compared to third-generation cephalosporins and penicillins, while bullous reactions were more often reported for first- and third-generation cephalosporins as opposed to second-generation cephalosporins and penicillins. The observed differences may be caused by differences between β-lactam antibiotics and their routes of administration (oral, intravenous), the patient populations, or the reporting of ADRs. Due to the methodological limitations of ADR database analysis, no conclusions can be drawn whether and to what extent the aforementioned factors influenced our results. Dustri-Verlag Dr. Karl Feistle 2022-02-03 /pmc/articles/PMC8822522/ /pubmed/35141466 http://dx.doi.org/10.5414/ALX02189E Text en © Dustri-Verlag Dr. K. Feistle https://creativecommons.org/licenses/by/2.5/This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Dubrall, Diana
Schulz, Maike
Schmid, Matthias
Sachs, Bernhardt
Descriptive analysis of adverse drug reaction reports for hypersensitivity reactions stratified in relation to different beta-lactam antibiotics
title Descriptive analysis of adverse drug reaction reports for hypersensitivity reactions stratified in relation to different beta-lactam antibiotics
title_full Descriptive analysis of adverse drug reaction reports for hypersensitivity reactions stratified in relation to different beta-lactam antibiotics
title_fullStr Descriptive analysis of adverse drug reaction reports for hypersensitivity reactions stratified in relation to different beta-lactam antibiotics
title_full_unstemmed Descriptive analysis of adverse drug reaction reports for hypersensitivity reactions stratified in relation to different beta-lactam antibiotics
title_short Descriptive analysis of adverse drug reaction reports for hypersensitivity reactions stratified in relation to different beta-lactam antibiotics
title_sort descriptive analysis of adverse drug reaction reports for hypersensitivity reactions stratified in relation to different beta-lactam antibiotics
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8822522/
https://www.ncbi.nlm.nih.gov/pubmed/35141466
http://dx.doi.org/10.5414/ALX02189E
work_keys_str_mv AT dubralldiana descriptiveanalysisofadversedrugreactionreportsforhypersensitivityreactionsstratifiedinrelationtodifferentbetalactamantibiotics
AT schulzmaike descriptiveanalysisofadversedrugreactionreportsforhypersensitivityreactionsstratifiedinrelationtodifferentbetalactamantibiotics
AT schmidmatthias descriptiveanalysisofadversedrugreactionreportsforhypersensitivityreactionsstratifiedinrelationtodifferentbetalactamantibiotics
AT sachsbernhardt descriptiveanalysisofadversedrugreactionreportsforhypersensitivityreactionsstratifiedinrelationtodifferentbetalactamantibiotics